Skip to main content

SFXN2 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88255

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-88255

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Format

BSA Free

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of SFXN2. Peptide sequence: AANCVNIPMMRQQELIKGICVKDRNENEIGHSRRAAAIGITQVVISRITM The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for SFXN2 Antibody - BSA Free

Western Blot: SFXN2 Antibody [NBP2-88255]

Western Blot: SFXN2 Antibody [NBP2-88255]

Western Blot: SFXN2 Antibody [NBP2-88255] - WB Suggested Anti-SFXN2 Antibody. Titration: 1.0 ug/ml. Positive Control: NCI-H226 Whole Cell

Applications for SFXN2 Antibody - BSA Free

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Format

BSA Free

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: SFXN2

Potential iron transporter

Alternate Names

sideroflexin 2, sideroflexin-2

Gene Symbol

SFXN2

Additional SFXN2 Products

Product Documents for SFXN2 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SFXN2 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...